Association between weight fluctuation and the risk of metabolic dysfunction-associated steatotic liver disease

Figure 1 Recent global prevalence of metabolic dysfunction-associated steatotic liver disease and recent prevalence of metabolic dysfunction-associated steatotic liver disease by continent. Figure 1 was created using ArcMap 10.2. Maps and data were separately sourced from publicly available resources on the websites (Resource and Environmental Science Data Platform, Geoboundaries, etc.) and literature surveys. Figure 1 now incorporates data obtained from recent epidemiological studies on MASLD. MASLD: Metabolic dysfunction-associated steatotic liver disease.

Figure 2 Flow chart. Metabolic dysfunction-associated steatotic liver disease development, total number of participants, exclusion criteria, final study group, incorporation of variables, and purpose of statistical analysis. HCC: Hepatocellular carcinoma; MASH: Metabolic dysfunction-associated steatohepatitis; MASL: Metabolic dysfunction-associated steatotic liver; MASLD: Metabolic dysfunction-associated steatotic liver disease; NHANES: National Health and Nutrition Examination Survey.

Figure 3 Arc diagram illustrates the association of exercise intensity and body fluctuation with metabolic dysfunction-associated steatotic liver disease risk based on odds ratio analysis. A: Early adulthood; B: Mid-to-late adulthood. OR: Odds ratio.